Pharma & MedTech
The pharmaceutical industry has repeatedly attracted attention through acquisitions worth billions. Hardly any other industry pays such gigantic purchase prices as the pharmaceutical sector. The media attention on these deals is correspondingly high. But besides these mega deals, the outlook on M&A in the medium-sized pharmaceutical and medical technology segment is even more promising. However, acting as advisor on such transactions requires knowledge of the special industry regulations and the related market structures.
Our relevant expertise in pharmaceutical and medical technology is not only reflected in respective transaction examples, but also as the author of several studies on M&A activities in these sectors. Furthermore, we are in constant communication with many market participants.
* Contains reference projects of former occupations of Dr. Thiele/Dr. Ulrich